DOCSLIB.ORG

Full Summit Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Full Summit Program Monday April 29, 2019 08:30 - 10:00 Opening Ceremony 10:00 - Coee Break 10:30 Hall A Hall B Hall C Hall D Hall E Hall F (Persian Gulf) (Razi) (Avicenna) (Kharazmi) (Shayan1) (Shayan2) 10:30 - Neglected Epidemics: The Role of Oral Strengthening Essential Air Pollution New Silk Roads Making War, Conict and Sanctions Ageing and Geriatric Medicine 12:00 Public Health to Advance Global Health Surgical Systems and Health for Global Health the Most of BRI Challenges for Global Health Kazem Malakouti Mohammad Reza Khami Ali Jafarian Kazem Nadda Kamran Abbasi Mostafa Ghanei Director General of Biotechnology ف Head of Gerontology, Iran University Director, Research Center for Caries Professor, Tehran University of Faculty Member, Tehran University of Executive Editor, The BMJ United Kingdom of Medical Sciences, I. R. of Iran Prevention, I. R. of Iran Medical Sciences, I. R. of Iran Medical Sciences, I. R. of Iran Development Council (BDC), I. R. of Iran Ilona Kiekbusch Heikki Murtomaa Paulo Saldiva Director.Global Health Centre Albrecht Jahn Academic Member, University John Meara Yik Ying Teo Researcher, University of Sao Paulo the Graduate Institute of Geneva, Switzerland Researcher, Heidelberg Institute of Helsinki, Finland Plastic Surgeon-in-Chief, Boston Dean, Saw Swee Hock School Brazil of Global Health , Germany of Public Health, National Usuf Chikte Children's Hospital & Director, Program in H.E. Yelzhan Amantayevich Birtanov Global Surgery Social Change, Harvard Minister of Healthcare Mehrnaz Kheirandish University of Singapore, Singapore Executive Head: Department of Global Health Reza Faridi Majidi University of Stellenbosch, South Africa Medical School, USA The Republic of Kazakhstan SDirector, Food & Tehran University of Drug Administration , I. R. of Iran Meri Tuulikki Koivusalo Mohammad Hossein Khoshnevisan Medical Sciences, I. R. of Iran Hongwei Cai Professor,Tampere University, Finland Director, Community Oral Health Dept., Shahid Hasan Emami Razavi Vice Director of Information Center First Wahid Majrooh Beheshti University of Medical Sciences, I. R. of Iran Senior International Relations Adviser Faculty Member.Tehran University of Vahid Hosseini Aliated Hospital of Xi'an Jiaotong Tomohiko Makino to the Minister of Public Health, Ministry Prathip Phantumvanit Medical Sciences, I. R. of Iran Government Employee, Department of University, China Medical Doctor, Ministry of Health of Public Health of Afghanistan, Afghanistan Dean, Faculty of Dentistry Thammasat Environment, I. R. of Iran Placella Enrichetta Labour and Welfare Japan, Japan University, Thailand Jorge Alberto Neira Deputy Head of Global Program Health, Batool Mousavi Member of the National Academy Swiss Agency for Development and Yohsuke Takasaki Nadereh Moosavi Fatemi Masud Yunesian Janbazan Medical and Engineering of Medicine, Argentina Cooperation (SDC), Switzerland Director, Ministry of Health, Labour Oral Health Expert, Oral Health Bureau Ministry Professor, Tehran University of Medical Research Center- JMERC, I. R. of Iran and Welfare Japan, Japan of Health and Medical Education, I. R. of Iran Alexander Peters sciences, I.R., Iran Amirhossein Takian Benoit Varenne Researcher Harvard Medical School Program Secretary, World Health Summit Regional World Health Organization Switzerland in Global Surgery and Social Change, USA Meeting 2019, I. R. of Iran 12:00 - 13:00 Hall A (Persian Gulf) Plenary I: Health in Uncertain Situations Moderator Mohammad Assai Ardakani Adviser to Minister for Public Health Ministry of Health and Medical Education I. R. of Iran H.E. Ferozuddin Feroz Minister of Public Health, Afghanistan Rana Hajjeh Director of Planning and Monitoring, WHO/EMRO, Egypt Reza Malekzadeh Vice Minister for Research Ministry of Health and Medical Education I. R. of Iran 13:00 - Lunch 14:00 14:00 - Nutrition and Healthy Road Accidents Global Health Climate Change Emerging & Networking in 15:30 Life Style and Trac Injuries and Religions & Health Re-emerging Diseases Medical Education Siamak Bidel Kamran B. Lankarani Detlev Ganten Ali Ardalan Minoa Mohraz John Joseph Norcini Jr Researcher, FAIMER USA Senior Medical Researcher Epidemiologist Professor of Medicine, Director of Iranian Founding President Manager, Health Systems in Emergencies Head of Iranian Research Center for HIV/ AIDS Helsinki University, Finland Research Network on Road Trac World Health Summit, Germany Lab (HSEL) Department of Health System Tehran University of Medical Sciences Safety., I. R. of Iran Nima Rezaei Development WHO Oce for Eastern I. R. of Iran Faculty Member,Tehran University of Mohammad Hossein Nicknam Mediterranean Region, I. R. of Iran Medical Sciences, I. R. of Iran Hamid Soori Permanent Member of the Iranian Academy Robert Sebbag Rassoul Dinarvand Researcher, Shahid Beheshti University of of Medical Sciences, I. R. of Iran Researcher, Hospital, France Farshad Allameh Chair and Professor of Pharmaceutics.TUMS' Medical Sciences, I. R. of Iran Abdelkader Allali Assistant Professor of Gastroenterology Director, Moroccan Association for Science and Technology Park, I. R. of Iran Ardeshir Khorshidian Imam khomeini Hosp ital, I. R. of Iran Health and Environment, Morocco Head of the Association Fardad Doroudi Farshad Farzadfar Country Director, UNAIDS, I. R. of Iran Charles lbingira Rukambura Abolghassem Djazayery of the Mobedan of Tehran, I. R. of Iran Associate Professor of Epidemiology Christoph Hamelmann Principal, Makerere University, Uganda Professor Emeritus of Nutrition, TUMS Non-Communicable Diseases Research Ciamak Morsadegh Representative, World Health Organization School of Nutritional Sciences Center Tehran University of Gonnie Klabbers Member of the Health Commission I. R. of Iran Rana Hajjeh and Dietetics, I. R. of Iran Medical Sciences, I. R. of Iran Department of Health Ethics and Society of the Parliament, I. R. of Iran Director of Planning and Monitoring Mostafa Mohaghegh WHO/EMRO, Egypt Faculty of Health Medicine and Life Sciences Tauque Joarder Dikran Sebouh Sarkissian Asia and Pacic Centre for the Development Maastricht University, the Netherlands Hamayaun Sadeghi-Bazargani Mohammad Mehdi Gouya Research Director, FHI 360 Bangladesh Archbishop of the Armenian Diocese of Disaster Information Management Chair, Road Trac Injury Research Center Director of CDC, Ministry of Health and Dainius Pavalkis of Tehran, I. R. Iran (APDIM), I. R. of Iran (National Iranian Trustee for Trac Medical Education, I. R. of Iran Advisor RISE HL to European Commission Knowledge Development) Associate Ex-minister of Education and Science Zahra Zeinal Professor of Epidemiology Abaas Ali Shameli of Lithuania, Lithuania Policy Ocer, EAT Foundation Norway Tabriz University of Medical Sciences, I. R. of Iran Global Center for the Islamic Sciences, Aluisio Segurado I. R. of Iran Faculty Member, Faculty of Medicine Fernando Regateiro University of Sao Paulo, Brazil CEO, Coimbra University Hospital Center, Portugal 15:30 - Coee Break 16:00 16:00 - 17:00 Hall A (Persian Gulf) Plenary II: Sustainable Health Development / UHC Moderator Mohsen Asadi Lari Director General for International Aairs, Ministry of Health and Medical Education, I. R. of Iran H.E. Yelzhan Amantayevich Birtanov Minister of Healthcare The Republic of Kazakhstan Detlev Ganten Founding President World Health Summit, Germany Assad Hafeez Director General, Ministry of Health, Pakistan, Pakistan Suwit Wibulpolprasert Global Health Advisor, Ministry of Public Health, Thailand Tuesday April 30, 2019 Hall A Hall B Hall C Hall D Hall E Hall F (Persian Gulf) (Razi) (Avicenna) (Kharazmi) (Shayan1) (Shayan2) 09:00 - Integration of Medical Social Mobilization Mental Health and Retaining Human Resources The Students' Capacity Disasters and 10:30 Education to Reach UHC Substance Abuse in Health Transition/ Brain Drain in Global Health Vulnerable Population Tahereh Changiz Ricardo Baptista Leite Selma Karabey Ali Akbar Haghdoost Detlev Ganten Hamidreza Khankeh Professor of Medical Education, Chancellor of Member of Portuguese Parliament Portugal Academic Member, Istanbul University Turkey Faculty Member, Kerman University Founding President World Health Summit Professor, Director, Research Center in Isfahan University of Medical Sciences I. R. of Iran Amirhossein Takian of Medical Sciences, I. R. of Iran Germany Emergency & Disaster Health, I. R. of Iran Afarin Rahimi Movaghar Boelen Charles Secretary, World Health Summit Martin Voss Director, Iranian National Center for Melika Haniha Medical Doctor, Consultant, France Regional Meeting 2019,1. R of Iran Charles lbingira Rukambura Educational Director for Student Program Researcher, Freie Universitat Berlin Germany Addiction Studies- INCAS, I. R. of Iran Principal, Makerere University, Uganda Mohammad Esmaeil Akbari Hamid Bohloli 7th WHS Regional Meeting, I. R. of Iran Benoit Miribel Director, Cancer Research Center Shahid Advisor & Head of Department ,Supreme Mazda Adli Academic Member, Teodor Blidaru Member of the Board of the Foundation Beheshti University of Medical Sciences Council of Health and Food Security Akbar Fotouhi Liaison Ocer, International Federation Christophe et Rodolphe Merieux, France I. R. of Iran Ministry of Health and Medical Education Charita - Universitiitsmedizin Berlin & Professor of Epidemiology, Department Fliedner Klinik Berlin, Germany of Medical Students Associations (IFMSA) Fereidoun Azizi I. R. of Iran of Epidemiology and Biostatistics School Romania Abbas Ostadtaghizadeh Distinguished Professor of Internal Medicine Ahmad Hajebi of Public Health,
Load more

Recommended publications
  • October 24–26, 2021 2
    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY & DIGITAL OCTOBER 24–26, 2021 2 “No-one is safe from COVID-19; “All countries have signed up to Universal no-one is safe until we are all Health Coverage by 2030. But we cannot safe from it. Even those who wait ten years. We need health systems conquer the virus within their that work, before we face an outbreak own borders remain prisoners of something more contagious than within these borders until it is COVID-19; more deadly; or both.” conquered everywhere.” ANTÓNIO GUTERRES Secretary-General, United Nations FRANK-WALTER STEINMEIER Federal President, Germany “We firmly believe that the “All pulling together—this must rights of women and girls be the hallmark of the European are not negotiable.” Health Union. I believe this can NATALIA KANEM be a test case for true global Executive Director, United Nations Population Fund (UNFPA) health compact. The need for leadership is clear and I believe the European Union must as- sume this responsibility.” “The lesson is clear: a strong health URSULA VON DER LEYEN system is a resilient health system. Health President, European Commission systems and preparedness are not only “Governments of countries an investment in the future, they are the that are doing well during foundation of our response today.” the pandemic have not TEDROS ADHANOM GHEBREYESUS Director-General, World Health Organization (WHO) only shown political leader- ship, but also have listened “If we don’t address the concerns and to scientists and followed fears we will not do ourselves a favor. their recommendations.” In the end, it is about how technology SOUMYA SWAMINATHAN Chief Scientist, World Health can be advanced as well as how Organization (WHO) we can make healthcare more human.” BERND MONTAG President and CEO, Siemens Healthineers AG, Germany “The pandemic has brought to light the “Academic collabo ration is importance of digital technologies and in place and is really a how it can radically bridging partnership.
    [Show full text]
  • Research Uses of Peptides from the Manning Lab 1980 – 2019
    Research Uses of Peptides from the Manning Lab 1980 – 2019 Over 3,000 samples have been donated to over 820 investigators (some multiple times) in the U.S. and worldwide for their own independent studies. See listings below. These studies have resulted in over 2,000 publications by these investigators. 1. Professor Roger Acher Laboratoire De Chimie Biologique Faculté des Sciences de l’Université de Paris 96, Boulevard Raspail-Paris V1 FRANCE 2. Eli Y. Adashi, M.D. Obstetrics & Gynecology University of Maryland School of Medicine & Hospital 22 South Greene Street Balitmore, MD 21201 3. Greti Aguilera, M.D. Chief Section on Endocrine Physiology DEB, NICHD, NIH Building 10, Room 10N262 10 Center Drive, MSC 1862 Bethesda, MD 20892-1862 4. Dr. K. Al Barazanji Mechanistic Pharmacology Dept. Vascular Biology SmithKline Beecham Pharmaceuticals The Frythe Welwyn, Hertfordshire, AL6 9AR UNITED KINGDOM 5. H. Elliott Albers, Ph.D. Professor of Biology and Psychology Georgia State University Department of Biology College of Arts and Sciences P.O. Box 4010 Atlanta, GA 30302-4010 6. Saad Al-Damluji, B.Sc., MRCP Lecturer in Endocrinology The Medical College of St. Bartholomew’s Hospital West Smithfield, LONDON, EC1A 7BE ENGLAND 7. Natalie Alexander, Ph.D. Department of Medicine University of Southern California School of Medicine 2025 Zonal Avenue Los Angeles, CA 90033 8. O.F.X. Almeida, Ph.D. Max-Planck-Institut Für Psychiatrie Deutsche Forschungsanstalt Für Psychiatrie Abteilung Neuropharmakologie AM Klopferspitz 18A 8033 Planegg-Martinsried WEST GERMANY 9. Dr. Meenakshi Alreja Associate Professor of Psychiatry and Neurobiology Yale University School of Medicine CMHC 335A, 34 Park Street New Haven, CT 06508 10.
    [Show full text]
  • Endoscopy During COVID-19 Pandemic
    DOI: 10.34172/mejdd.2020.186 Editorial 217 Endoscopy during COVID-19 Pandemic Anahita Sadeghi 1, Kamran Bagheri Lankarani 2,* Please cite this paper as: 1. Digestive Disease Research Institute, Sadeghi A, Bagheri Lankarani K. Commentary: Endoscopy during COVID-19 Tehran University of Medical Sciences, Pandemic. Middle East J Dig Dis 2020;12:217-219. doi: 10.34172/mejdd.2020.186. Tehran, Iran 2. Health Policy Research Center, Shiraz INTRODUCTION University of Medical Sciences, Shiraz, Iran The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses a major global health threat. The infected patients may present with a broad spectrum of clinical signs and symptoms, from being asymptomatic to developing flu-like symptoms or pneumonia, acute respiratory distress syndrome, multi- organ failure, and death. 1, 2 Gastrointestinal symptoms are also common in patients with COVID-19, and some cases may first present with nausea, vomiting, and diarrhea even without other symptoms. 3, 4 Although viral transmission is primarily through small respiratory droplets and direct contact, there is also the possibility of both bioaerosol transmission and fecal contamination.4 Furthermore, there is evidence of viral shedding in asymptomatic subjects or during the long incubation period of the virus. 5 That is why all healthcare providers, staff, and even patients of the endoscopy department are at great risk of COVID-19 infection, and therefore, special precautions for disease prevention should be taken to ensure their safety. Gastroenterologists are at higher risk for COVID-19 by respiratory and fecal-oral routes. Among 480 gastroenterologists, 10.6% had confirmed COVID-19 in Iran. 6 With this background, the “Guideline on Endoscopy during COVID-19 Pandemic” in Iran was compiled and edited based on the consensus of a group of gastroenterologists on the latest knowledge and international guidelines, as well as the survey of colleagues’ opinions and experiences in this context.
    [Show full text]
  • Curriculum Vitae
    Curriculum Vitae Personal Information Name: Ramin Niknam Associate professor of Gastroenterology and Hepatology MD Shiraz University of Medical Sciences (SUMS) Completion date: 2020 Publications of Articles 1. COVID-19 in Liver Transplant Patients: Report of 2 Cases and Review of the Literature. International Medical Case Reports Journal 2020:13 2. Association Between Metabolic Syndrome and Its Components with Severity of Acute Pancreatitis. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2020:13 3. Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2020:13 4. Socioeconomic - related inequalities in overweight and obesity: findings from the PERSIAN cohort study. BMC Public Health; (2020) 20:214 5. A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial. Acta Biomed 2020; Vol. 91, N. 1: 70-78 1 6. Leiomyosarcoma of the Inferior Vena Cava with Cardiac Extension; A Rare Cause of Acute Liver Failure. Govaresh/ Vol. 25, No.1, Spring 2020; 73-76. 7. The pregnancy-associated gastric cancer: a case report and review of the literature. J Obstet Gynaecol. 2020 Jan 20:1-2. 8. The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density. December 2019. Risk Management and Healthcare Policy Helicobacter pylori, Endoscopic, And Histologic Features Among Kidney Transplant Candidates In Southern Iran. Infection and Drug Resistance. November 2019. 9. Community pharmacists’ knowledge, attitude, and practice of Irritable Bowel Syndrome (IBS): the impact of training courses. June 2019 10. Economic impact of pharmacist interventions on correction of stress-related mucosal damage prophylaxis practice.
    [Show full text]
  • Development of Gastroenterology and Hepatology in Iran: Part II-Advances in Research and Therapeutic Modalities
    Arch Iranian Med 2009; 12 (5): 516 – 525 History of Contemporary Medicine Development of Gastroenterology and Hepatology in Iran: Part II-Advances in Research and Therapeutic Modalities Mehdi Saberifiroozi MD•*,**, Seid-Hossein Mir-Madjlessi MD*,*** Abstract The first attempts to start research activities and try Following the establishment of Gastroenterology to publish papers in this field were started in Shiraz and Hepatology Fellowship Programs in 1987, and Tehran after 1960.2,3 According to published significant developments in research and health articles, the major diseases during 1970’s were care delivery have been achieved. The number of published articles has increased significantly and upper GI cancers, liver cirrhosis of liver, now more than 10 approved research centers are immunoprolifertive small intestinal disease involved in several longitudinal and population (IPSID), and peritoneal tuberculosis. According to based studies in GI epidemiology, viral hepatitis and K. Nasr important factors which promoted the GI oncology around the country. research activities in Shiraz University in the Before 1987 less than 50 gastroenterologists were working in the country, but now more than 300 1960s and 1970s were: requirement of publication gastroenterologists are involved in public and in good journals for academic promotion, full time private health care delivery systems. Advanced system for academic staff, good medical charts in diagnostic and therapeutic endoscopic procedures hospitals, good laboratory, pathology and and complex surgical procedures such as liver transplantation are a routine now. radiology services, and very high rates of autopsy, These achievements are indicative of hard work which were available in a few academic centers at and determination of dedicated physicians after the that time.4 It should be emphasized that in the 90s Islamic Revolution, and the support of governmental and after 2000, significant improvements have and non-governmental sectors.
    [Show full text]
  • World Health Summit Berlin, Germany October 09–11, 2016
    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY OC TOBER 09–11, 2016 FEDERAL FOREIGN OFFICE | BERLIN I am convinced the “ World Health Summit will add valuable The World Health Summit impetus and wish all “ is an excellent venue for participants interesting expert discussion on the and enlightening days. health topics that move us Hermann Gröhe Federal Minister of Health, Germany” worldwide. We can expect it to deliver valuable input. Angela Merkel Chancellor of the ” Your involvement and Federal Republic of Germany “ your declarations at this World Health Summit will play an important role in informing the international community. François Hollande President of the French Republic ” FACTS WORLD HEALTH SUMMIT 2016 | 3 3 DAYS · 40 SESSIONS · 250 SPEAKERS From October 9–11, the 8th World Health Summit will once Patronage again draw international experts from academia, politics, Angela Merkel Federal Chancellor of Germany the private sector, and civil society to the German Federal François Hollande Foreign Oce in Berlin. President of France Jean-Claude Juncker At the World Health Summit (WHS), more than 1,500 stakeholders and President of the decision-makers from every field in the healthcare spectrum will work European Commission together to find solutions to global health challenges. Presidents 2016 The world’s foremost strategic forum for global health, it promotes thought Antoine Flahault leadership in science and global health agendas. The World Health Summit University of Geneva was founded in 2009 on the occasion
    [Show full text]
  • Global Health – Do Think Tanks Matter?
    Global Health – Do Think Tanks Matter? Organised by the Global Health Programme at the Graduate Institute Biographies of Speakers 13 November 2015 Maison de la paix The Graduate Institute, Geneva WELCOME AND INTRODUCTORY REMARKS BY THE MODERATOR OF THE SESSION ILONA KICKBUSCH Director, Global Health Programme, the Graduate Institute Ilona Kickbusch is the Director of the Global Health Programme at the Graduate Institute of International and Development Studies, Geneva. She is senior advisor to the Regional Directors of the WHO Regional Offices for Europe and the Eastern Mediterranean. She has been deeply involved in the development of the Health 2020 European health policy framework. She is a member of the independent Ebola interim assessment panel of the WHO. In Switzerland, she serves on the executive board of the Careum Foundation and on the expert panel to the Federal Councillor to advise on the implementation of the Swiss Health Strategy 2020. She has contributed to innovation in health in many ways throughout her career and now advises organisations, government agencies and the private sector on policies and strategies to promote health at the national, European and international level. She has worked with the WHO at various levels and in academia as professor at Yale University. She has received honorary doctorates from the Nordic School of Public Health and the University of Girona. She has published widely and is a member of a number of advisory boards in both the academic and health policy arenas. She has received many awards. Her key areas of work relate to Global Health Governance, Health Security, Public Health, Health Promotion, Health Literacy, and Health in All Policies.
    [Show full text]
  • Detlev Ganten
    Detlev Ganten * 28. 3. 1941 Lüneburg Der Mediziner Detlev Ganten arbeitet in der Bluthochdruckforschung und über die molekulare Genetik von Herz-Kreislauf-Erkrankungen. 1997/98 war Ganten Präsident der GDNÄ und referierte z. B. 1994 in Hamburg über Die Genetik des Bluthochdrucks: Molekulare Analyse einer Volkskrankheit. Detlev Ganten studierte ab 1962 Medizin in Würzburg, Montpellier (Frankreich) und Tübingen und war an der chirurgischen Abteilung des französischen Krankenhauses in Marrakesch tätig. Das Studium schloss er 1968 mit der Promotion ab. Zwischen 1969 und 1973 hielt er sich für For- schungszwecke am Clinical Research Institute in Montreal auf und erwarb den Doctor of Philosophy (PhD) von der McGill University. 1975 erhielt Ganten einen Ruf an das Pharmakologische Institut der Universität Heidel- berg und war anschließend ab 1992 Gründungsdirektor des Max-Delbrück- Centrums für Molekulare Medizin in Berlin-Buch. Parallel dazu war Ganten bis 2004 Professor für Klinische Pharmakologie am Universitätsklinikum der FU Berlin. In seiner wissenschaftlichen Arbeit beschäftigt sich Ganten insbesondere mit dem hormonalen Renin-Angiotensin-System, das u.a. für die Erhöhung des Blutdrucks verantwortlich ist. Daneben forscht er zur An- wendung transgener Techniken im Bereich der Herz-Kreislauf-Regulation und zu den genetischen Ursachen von Bluthochdruck. Ganten ist Heraus- geber des Journal of Molecular Medicine und des Handbook of Experimental Phar- macology. Außerhalb der wissenschaftlichen und medizinischen Arbeit war Gan- ten von 1993 bis 1998 Mitglied im Wissenschaftsrat der Bundesrepublik Deutschland, saß von 2002 bis 2007 im Nationalen Ethikrat und war von 2004 bis 2008 Vorstandsvorsitzender der Charité. Zwischen 1997 und 2001 war er Präsident der Helmholtz-Gemeinschaft Deutscher Forschungszent- ren.
    [Show full text]
  • M8 Alliance Expert Meeting on Migrants' and Refugees' Health 23
    M8 Alliance Expert Meeting on Migrants’ and Refugees’ Health 23-24 June 2017 Venue: Rectorate Building, Sapienza University of Rome, P.le Aldo Moro 5, Rome Hosted by Sapienza University of Rome in cooperation with Charité – Universitätsmedizin Berlin, the University of Geneva, the University of Montreal, the Université Sorbonne Paris Cité, the Centre Virchow-Villermé for Public Health Paris-Berlin, Tehran University of Medical Sciences and the Italian Society of Migration Medicine Overall Chair: Luciano Saso, Faculty of Pharmacy and Medicine, Vice-Rector for European University Networks Sapienza University, Sapienza's Representative in the M8 Alliance 23 June, 2017 11.00 Conferral of Honorary Doctorate on Prof. Detlev Ganten (Senate Hall, Rectorate Building, 1st floor) 13:00-14:00 Registration and light lunch (Room “Organi Collegiali”, Rectorate Building, ground floor) 14:00 -14:25 Welcome Addresses Eugenio Gaudio, Rector of Sapienza University of Rome Detlev Ganten, President of the World Health Summit, Berlin Delegate of Beatrice Lorenzin, Minister of Health, Italy Susanne Wasum-Rainer, Ambassador, Embassy of the Federal Republic of Germany in Italy Hinrich Thölken, Ambassador, Permanent Representation of the Federal Republic of Germany to the International Organizations in Italy 14:25 -14:45 Introduction Paolo Villari, Director of the Department of Public Health and Infectious Diseases, Sapienza University of Rome Axel Pries, Dean, Charité, Universitätsmedizin Berlin Vincenzo Vullo, Dean of the Faculty of Pharmacy and Medicine, Sapienza University of Rome Sebastiano Filetti, Dean of the Faculty of and Medicine and Dentistry, Sapienza University of Rome Massimo Volpe, Dean of the Faculty of and Medicine and Psychology, Sapienza University of Rome 14:45-17:00 Session 1A.
    [Show full text]
  • 2 of the Collège De France
    The Letter 2 of the Collège de France N°2 Academic year 2006-2007 Editorial The Collège de France’s new Scientific and Strategic Orientation Committee (COSS) by Pierre Corvol Administrator ‘Today’s world is seeking references, reasons to marvel, of the Collège de France ambitious motivating projects. With the sole objective of Professor, furthering knowledge, basic research – that essentially holder of the Chair of Experimental Medicine disinterested research which demands real collaboration at international level – is one of the paths on that quest. Science is and will always remain a factor of emancipation for humans the university world through the PhD schools, increasing and it is important today to emphasize that obvious fact. In this relations with foreign universities, and developing research at the context, the Collège de France has a unique position in France Collège itself. Today a progress report is indispensable. The and in Europe but also in the world.’ These are the introductory Collège will be attentive to the COSS’s opinions on these points, lines of the Annual Report of the International Scientific and as these will enable it to focus its strategy on the objectives that Strategic Orientation Committee (COSS) submitted to the the Committee has reviewed and revised. President of the Republic, the Prime Minister and the Collège de France’s supervisory ministries in May 2004. The COSS meeting in March 2007 enabled it to make contact with the members of the extended executive of the The creation of the COSS in 2003, on the Collège’s Collège and certain professors at the Cardinal Lemoine and initiative, stemmed from the wish to benefit from eminent Ulm sites.
    [Show full text]
  • Table of Contents Title Page
    Table of Contents Title Page 1 Preface The first edition of Iranian Academy of Medical Sciences' book published in 2006 was aimed to introduce permanent members of this academy and its scientific structure. Considering the development of strategic planning of the Academy in 2010, modification of the statute of Iranian Academy of Medical Sciences in 2011 and also election of new permanent members, the preparation and publication of the second edition of Iranian Academy of Medical Sciences' book seemed unavoidable. The scientific and functional structures of the Iranian Academy of Medical Sciences like all other academicals centers in the world has been evaluated upon opportunities, threatens and experiences in the past years and they have been developed into strategic plan that a summary of it and new statute of the Academy are included in this book. Another important part of this book is introduction and provision of a summary on scientific background of permanent member of the Academy. A brief summary on scientific background of each permanent member is finalized by the help of them and a frequent follow-up and will be more completed in next editions. The Iranian Academy of Medical Sciences look forward to carry out the monitoring and theorizing mission in countries' health section with the help of professors, researchers and scholars in all fields of medical sciences and is very keen to take advantages of the guidance and experience of theoretical and practical knowledge of science lovers along with the aims and goals of the Academy Dr. Seyed Alireza Marandi President President of Iranian Academy of Medical Sciences 2 Honorary Members Name Date of Membership Esmail Meisami; Ph.D.
    [Show full text]
  • World Health Summit Berlin, Germany October 15–17, 2017
    S ECCI N E · InnOVATION · POLICIES WORLD HEALTH SUMMIT B ERLIN, GERMANY O CTOBER 15–17, 2017 FACTS WORLD HEALTH SUMMIT 2017 | 3 3 DAYS · 40 SESSIONS · 250 SPEAKERS From October 15–17, the 9th World Health Summit will draw Patronage inter national experts from academia, politics, the private sector, Angela Merkel and civil society to Berlin. Chancellor of the Federal Republic of Germany At the World Health Summit (WHS), more than 1,600 stakeholders François Hollande * and decision-makers from over 80 countries and every field in the President of France healthcare spectrum will work together to find solutions to global Jean-Claude Juncker * health challenges. President of the European Commission The world’s foremost strategic forum for global health, it promotes thought leadership in science and advances global health agendas. Presidents 2017 The World Health Summit was founded in 2009 on the occasion of Hélène Boisjoly the 300th anniversary of Berlin’s Charité Hospital. Université de Montréal Detlev Ganten Charité – Universitätsmedizin Berlin PROGRAM STRUCTURE Participants SUNDAY, OCT 15, 2017 • More than 1,600 decision makers 10:30 from over 80 countries on site 13:00 • More than 3,000 people 15:00 worldwide via online live-stream 17:00 WHS OPENING CEREMONY Results • The M8 Alliance Declaration MONDAY, OCT 16, 2017 • Session Reports 9:00 • Statements and recommendations 11:00 made at the WHS are passed on to 13:00 WHS Startup Track National Academies, Governments, 14:00 and International Organizations 16:00 19:00 WHS Night Regional Meetings
    [Show full text]